AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 253: H507-H511, 1987;
0363-6135/87 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sandor, P.
Right arrow Articles by de Wied, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sandor, P.
Right arrow Articles by de Wied, D.

AJP - Heart and Circulatory Physiology, Vol 253, Issue 3 507-H511, Copyright © 1987 by American Physiological Society

ARTICLES

Central opioid mechanisms and cardiovascular control in hemorrhagic hypotension

P. Sandor, W. de Jong, V. Wiegant and D. de Wied

Bleeding volume during standardized hemorrhagic hypotension was studied in anesthetized, artificially ventilated rats after specific stimulation or blockade of opiate receptor systems. Hypotension was produced by stepwise bleeding to 80, 60, and 40 mmHg systemic arterial pressure. Subcutaneous administration of morphine 15 min before the bleeding resulted in a decrease, whereas subcutaneous administration of naloxone resulted in a significant increase in the required bleeding volume. Intracerebroventricularly administered met-enkephalin, dynorphin, or specific antisera against these peptides caused no characteristic alterations of the bleeding volume although met-enkephalin and dynorphin caused a significant decrease at the 40 mmHg level. Bleeding volume, however, was markedly reduced when beta-endorphin was intracerebroventricularly administered and significantly elevated by intracerebroventricular administration of a diluted beta-endorphin antiserum. These data suggest that 1) opioid mechanisms are participating in the control of blood pressure and of bleeding volume during blood loss, 2) these control mechanisms might be activated centrally, and 3) beta-endorphin or a closely related peptide plays a major role in these control mechanisms.


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
S. Cavun, G. E. Resch, A. D. Evec, M. M. Rapacon-Baker, and W. R. Millington
Blockade of Delta Opioid Receptors in the Ventrolateral Periaqueductal Gray Region Inhibits the Fall in Arterial Pressure Evoked by Hemorrhage
J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 612 - 619.
[Abstract] [Full Text]

Home page
 J. Neurophysiol.Home page
A. Hayar and P. G. Guyenet
Pre- and Postsynaptic Inhibitory Actions of Methionine-Enkephalin on Identified Bulbospinal Neurons of the Rat RVL
J Neurophysiol, October 1, 1998; 80(4): 2003 - 2014.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. D. Owen, S. Gurun, G. P. Zaloga, and W. R. Millington
Glycyl-L-glutamine [beta -endorphin-(30---31)] attenuates hemorrhagic hypotension in conscious rats
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1997; 273(5): R1598 - R1606.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
L. Guasti, R. Cattaneo, O. Rinaldi, M. G. Rossi, L. Bianchi, G. Gaudio, A. M. Grandi, G. Gorini, and A. Venco
Twenty-Four–Hour Noninvasive Blood Pressure Monitoring and Pain Perception
Hypertension, June 1, 1995; 25(6): 1301 - 1305.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online